CLDN2 and neoplasm: When considering both markers simultaneously, patients were stratified into four groups according to Claudin-2 and Afadin expression within the primary tumor: Claudin-2low/Afadinlow, Claudin-2low/Afadinhigh, Claudin-2high/Afadinlow, and Claudin-2high/Afadinhigh.